Oncology
Conference Coverage
In the previous year, 70% of oncologists reported sexual harassment
“The survey’s recall period [about harassment] was in the previous 12 months. The respondents weren’t reflecting on a lifetime of events.”
Conference Coverage
Free U.K. tool could help guide COVID-19 care for cancer patients
Conference Coverage
NSCLC: Immune-related AEs during checkpoint inhibitor therapy may predict outcomes
News
Elevated factor VIII troughs can lead to a higher proportion of zero bleeds in hemophilia
Outcomes Research in Review
Differences in Palliative Care Delivery Among Adults With Cancer and With Terminal Noncancer Illness in Their Last Year of Life
News
FDA OKs nivolumab after surgery for esophageal or GEJ cancer: Practice-changing use of immunotherapy
A 1-year course of adjuvant nivolumab did not negatively impact patient-reported quality of life, the trialists reported.
Conference Coverage
‘Inflammasomes’ may play a role in obesity-related CRC
FDA/CDC
FDA approves new treatment option for rare anemia
Pegcetacoplan (Empaveli) was approved as a treatment for paroxysmal nocturnal hemoglobinuria (PNH).
News
Possible obesity effect detected in cancer death rates
As with heart disease, declines in mortality for some cancers seem to be affected by the obesity epidemic.
FDA/CDC
FDA okays upfront pembro for advanced HER2+ gastric cancer
The accelerated approval is for first-line use in combination with other agents for locally advanced unresectable or metastatic HER2-positive...